Introduction
In their otherwise comprehensive review of signaling mechanisms in sweet taste, von Molitor et al. (2021) missed research on human sweet taste modeling that originated in pharmacokinetics. This research predates the receptor characterization that they reviewed by about a decade and was conducted in humans. The von Molitor et al. paper, published in a journal devoted to human neuroscience, appropriately begins with a background on sugar consumption and health in humans. The paper goes on to provide a brief overview of the severe limitations associated with human experimentation and concludes that “taste-related signaling mechanisms have been studied mainly in rodents, although there are major species-related differences”. This commentary will provide a brief account of the methodology, models, and conclusions from the omitted research to augment the von Molitor et al. review.
Transduction mechanisms in human taste
Black was awarded the Nobel prize in Physiology or Medicine for the science behind the two blockbuster drugs of the twentieth century: propranolol (a beta blocker) and cimetidine (a histamine receptor antagonist). His Nobel lecture (Black, 1989), entitled Drugs from emasculated hormones: the principle of syntopic antagonism, vividly entertained the idea of a two-stage process for creating blockers. This process consisted in fruitful receptor binding without subsequent transducer action, and thus separated and exploited these two stages. Black and Leff (1983) had previously published a mathematical model that provided parameters for the two stages called affinity and efficacy and these refer to the initial receptor binding and the subsequent participation of a transducer, such as a G-protein. The possible common evolutionary ancestry of the mechanisms for heart stimulation, vision, taste, and smell (Lancet et al., 1988) suggested that this two-stage model may have value in modeling the chemical senses, including sweet taste (Pace et al., 1985; Anholt, 1987). Support for this hypothesis had not yet been demonstrated, however, in humans.
Pharmacokinetic models for sweet taste mixtures in humans
Developing and testing a model for smell and taste in humans poses some challenges because human experimentation necessarily involves chemosensory psychophysics. This means that measurements are made at some distance from the site of action. An opportunity to expand and test an extension of Black and Leff's model for single substances to mixtures of agonists occurred when DeGraaf and Frijters (1986) published experimental results on the points of subjective equality of glucose and fructose mixtures following Beidler (1962). These authors considered common receptor binding without the participation of a transducer and did not develop and test models with independent receptors or models with common or independent receptor-transducer systems. Common receptor binding means that competitive agonism occurs between the two substances and independent binding means that it does not. Independent receptor-transducer systems are those in which competition does not occur between the mixture components for the receptor or transducer. Plots of equal sweetness of the single substances and mixtures of them are called isoboles (Ennis, 1991), which may be linear (no synergy) or non-linear (synergy). An advantage of comparative mixture experiments is that it is not necessary to know the precise function that connects the periphery to the percept, only that it is monotonic. The modeling challenge was to develop equations from the law of mass action that included the binding constants for each substance to independent or common receptors and for independent or common receptor-transducer systems, if they occurred. The equations for the four derived models are given in Table 1 (summarized from Ennis, 1991, 1996). Figure 1 shows the fit of the data to independent receptors and independent receptors coupled to a transducer (Ennis, 1991, Figure 2). The common receptor and common receptor-transducer models (involving competitive agonism) were ruled out because they cannot explain synergy since their isoboles are linear. The best-fitting model was the independent (non-competitive) receptor-transducer model which was significantly superior to the independent receptor model without participation of a transducer as shown in Figure 1. Other models, such cooperative binding models where both substances may act together on receptor sites, were less parsimonious than the simple binding, independent receptor-transducer model. This research showed, for the first time, that human chemical sensing involves a transducer entity, such as a G-protein. Model parameters for affinity and efficacy in humans, as defined by Black and Leff (1983), were determined by Ennis (1991, 1996) using non-linear least squares to determine the model parameters for each model using the Levenberg-Marquart algorithm. It was shown that fructose is sweeter than glucose because its receptor affinity is higher than glucose, although its efficacy or transducer engagement, is weaker. Subsequently, the mixture models were used to study synergy between fructose, sucralose and high potency sweeteners (Wolf et al., 2010).
Table 1
| Common | Independent | |
|---|---|---|
| Receptor | [Bm] = k ([A] – [Am]), k = | [Bm] = |
| Receptor-transducer | [Bm] = , where β= Ka – αKb α = | [Bm] θ = 1 + β[A]+[Am]{Ka(1+2τ)+αKb}+ [A]α = β= Ka – αKb, and τ = Kar[R] |
Receptor and receptor-transducer models assuming common and independent systems.
[Am] and [Bm] refer to the concentrations of glucose and fructose in mixtures, respectively. [A] refers to a target concentration of one of the mixture components (glucose) and is a known constant to which the mixtures are compared. Ka and Kb refer to binding constant to receptors (affinity). Kar and Kbr refer to agonist-receptor binding to a transducer (efficacy). R refers to the concentrations of the receptors in the independent systems which are assumed to be equal (summarized from Ennis, 1991, 1996).
Figure 1
Conclusions
von Molitor et al. limited their consideration of human psychophysical tests to detection, intensity and hedonic measurements from subject reports. However, a much richer vein of exploration in humans can be pursued by considering how to apply models developed in pharmacokinetics and expanded to include mixtures of substances with similar effects, such as sweeteners or drugs. From this research, it was shown that a transducer exists in human sweet taste, that fructose and glucose operate on independent systems which leads to synergy, and that the affinity of fructose is greater, and its efficacy weaker, than glucose. This research put chemosensory psychophysics on a molecular foundation.
Statements
Author contributions
The author confirms being the sole contributor of this work and has approved it for publication.
Conflict of interest
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AnholtR. R. H. (1987). Primary events in olfactory reception. Trends Biochem. Sci.12, 58–62. 10.1016/0968-0004(87)90031-4
2
BeidlerL. M. (1962). Taste receptor stimulation. Prog. Biophys. Biophys. Chem.12, 109–151. 10.1016/S0096-4174(18)30231-2
3
BlackJ. W. (1989). Drugs from emasculated hormones: the principle of syntopic antagonism. Angew. Chem. Int. Ed. Engl. 28, 886–894. 10.1002/anie.198908861
4
BlackJ. W.LeffP. (1983). Operational models of pharmacological agonism. Proc. R. Soc. Lond. B220, 141–162. 10.1098/rspb.1983.0093
5
DeGraafC.FrijtersJ. E. R. (1986). A psychophysical investigation of Beidler's taste equation. Chem. Senses11, 296–314. 10.1093/chemse/11.3.295
6
EnnisD. M. (1991). Molecular mixture models based on competitive and non-competitive agonism. Chem. Senses16, 1–17. 10.1093/chemse/16.1.1
7
EnnisD. M. (1996). A general molecular model for the effect of multi-component mixtures on biological systems. Food Chem.56, 329–335. 10.1016/0308-8146(96)00057-X
8
LancetD.LazardD.HeldmanK. M.NefP. (1988). Molecular transduction in smell and taste. Cold Spring Harbor Symp. Quant. Biol.53, 343–348. 10.1101/SQB.1988.053.01.041
9
PaceU.HanskiE.SalomonY.LancetD. (1985). Odorant-sensitive adenylate cyclase may mediate olfactory reception. Nature316, 255–258. 10.1038/316255a0
10
von MolitorE.RiedelK.KrohnM.HafnerM.RudolfR.CesettiT. (2021). Sweet taste is complex: signaling cascades and circuits involved in sweet taste. Front. Hum. Neurosci.15, 1–28. 10.3389/fnhum.2021.667709
11
WolfP. A.BridgesJ. R.WicklundR. (2010). Application of agonist-receptor modeling to the sweetness synergy between high fructose corn syrup and sucralose, and between high-potency sweeteners. J. Food Sci. 75, S95–S102. 10.1111/j.1750-3841.2009.01463.x
Summary
Keywords
sweet, taste, receptor, transducer, pharmacokinetics, chemosensory psychophysics, models, agonist
Citation
Ennis DM (2023) Commentary: Sweet taste is complex: Signaling cascades and circuits involved in sweet sensation. Front. Hum. Neurosci. 17:1167749. doi: 10.3389/fnhum.2023.1167749
Received
16 February 2023
Accepted
13 March 2023
Published
29 March 2023
Volume
17 - 2023
Edited by
Thiago P. Fernandes, Federal University of Paraíba, Brazil
Reviewed by
Rüdiger Rudolf, Mannheim University of Applied Sciences, Germany
Updates
Copyright
© 2023 Ennis.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Daniel M. Ennis daniel.m.ennis@ifpress.com
This article was submitted to Sensory Neuroscience, a section of the journal Frontiers in Human Neuroscience
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.